This medication, acting as a GLP-1 receptor agonist, plays a significant role in appetite control and insulin regulation
O.Aharon-PeretzJ.AnnesiG.BarbosaE
Ti-EVs isolated from melanoma, with a higher expression of mitochondrial membrane proteins, were different from cell-line-derived EVs
On average, clinical studies have shown that patients can lose 5% to 15% of their body weight within 6 months of using Wegovy
Ethics declarations Competing interests S.F
While the nephroprotective effects of SGLT2i were initially derived from secondary endpoints of CV outcome trials (CVOTs), direct confirmation came from dedicated kidney focused trials: CREDENCE (Perkovic et al NEJM 2019| NephJC Summary), DAPA-CKD (Heerspink et al NEJM 2020| NephJC Summary) and finally EMPAKIDNEY (Herrington et al NEJM 2023| NephJC Summary)